Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • Anonymous
    Participant
    Post count: 93172

    Here is an article from Reuters someone sent me regarding Graves’ eyes and
    smoking. The source for the article is listed at the end

    Thursday October 15 1:52 PM EDT

    Smoking affects Graves’ disease treatment

    NEW YORK, Oct 15 (Reuters) — Smoking reduces the effectiveness of
    treatments for the eye complications of Graves’ disease, according to
    researchers in Italy.

    Graves’ disease is an autoimmune disease characterized by an enlarged
    thyroid. Patients with the disease can also develop eye symptoms,
    including abnormal protrusion of the eyeball, blurred or double vision.

    Cigarette smoking is a risk factor for eye complications of Graves’
    disease, Dr. Luigi Bartalena of the University of Pisa and colleagues
    explain in the October 15th issue of Annals of Internal Medicine. They
    set out to determine whether or not smoking also affected treatment
    outcomes in patients with the disorder.

    The researchers reviewed the outcomes of 300 Graves’ disease patients
    with mild eye symptoms and 150 with severe eye complications. Patients
    in the first group were treated with radioiodine, either alone or in
    combination with steroid therapy. Patients in the second group all
    received steroids and underwent radiation therapy targeting the eye.

    Among patients with mild eye symptoms, smokers were more likely to
    experience disease progression after radioiodine therapy compared with
    nonsmokers, with rates of 23.2% and 5.9%, respectively. In addition,
    radioiodine plus steroid therapy was more than
    four times more effective in alleviating mild eye symptoms in
    nonsmokers than in smokers, Bartalena and colleagues report.

    The same association between treatment outcome and smoking status was
    observed in patients with more severe forms of the disease. According
    to the report, the combination of high-dose steroids and eye
    irradiation was more likely to offer benefits to nonsmokers than to
    smokers.

    The findings “suggest that cigarette smoking increases the risk for
    progression of (eye complications) after radioiodine therapy and
    decreases the efficacy of orbital irradiation and steroids,” the
    Italian investigators conclude. They recommend that patients with eye
    complications of Graves’ disease “should be strongly encouraged to
    refrain from smoking.”

    SOURCE: Annals of Internal Medicine 1998;129:632-635.

    Anonymous
    Participant
    Post count: 93172

    JeanC posted this article last fall. Since the effects of smoking with Graves’ eye disease has been brought up on the BB again, I thought it would be appropriate to post it again.

    Debby

    SOURCE: Annals of Internal Medicine 1998;129:632-635.

    Smoking affects Graves’ disease treatment

    NEW YORK, Oct 15 (Reuters) — Smoking reduces the effectiveness of
    treatments for the eye complications of Graves’ disease, according to
    researchers in Italy.

    Graves’ disease is an autoimmune disease characterized by an enlarged
    thyroid. Patients with the disease can also develop eye symptoms,
    including abnormal protrusion of the eyeball, blurred or double vision.

    Cigarette smoking is a risk factor for eye complications of Graves’
    disease, Dr. Luigi Bartalena of the University of Pisa and colleagues
    explain in the October 15th issue of Annals of Internal Medicine. They
    set out to determine whether or not smoking also affected treatment
    outcomes in patients with the disorder.

    The researchers reviewed the outcomes of 300 Graves’ disease patients
    with mild eye symptoms and 150 with severe eye complications. Patients
    in the first group were treated with radioiodine, either alone or in
    combination with steroid therapy. Patients in the second group all
    received steroids and underwent radiation therapy targeting the eye.

    Among patients with mild eye symptoms, smokers were more likely to
    experience disease progression after radioiodine therapy compared with
    nonsmokers, with rates of 23.2% and 5.9%, respectively. In addition,
    radioiodine plus steroid therapy was more than
    four times more effective in alleviating mild eye symptoms in
    nonsmokers than in smokers, Bartalena and colleagues report.

    The same association between treatment outcome and smoking status was
    observed in patients with more severe forms of the disease. According
    to the report, the combination of high-dose steroids and eye
    irradiation was more likely to offer benefits to nonsmokers than to
    smokers.

    The findings “suggest that cigarette smoking increases the risk for
    progression of (eye complications) after radioiodine therapy and
    decreases the efficacy of orbital irradiation and steroids,” the
    Italian investigators conclude. They recommend that patients with eye
    complications of Graves’ disease “should be strongly encouraged to
    refrain from smoking.”

Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.